Matthew Rosebraugh
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 17, 2025
A Modeling Investigation of the CYP1A Drug Interactions of Riluzole.Paul Malik, Paola Mian, Jinsy Andrews
|Apr 10, 2024
Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC-HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel.John P Savaryn, Richard L Smith, Matthew Rosebraugh
|Sep 12, 2022
Phase 1 Evaluation of Elezanumab (Anti-Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants.Hari V Kalluri, Matthew R Rosebraugh, Thomas P Misko
|Mar 27, 2021
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease.Matthew Rosebraugh, Eric A Voight, Ehab M Moussa
|Apr 13, 2019
Levodopa-carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulation.Matthew Rosebraugh, Hari V Kalluri, Wei Liu
Pageof 1
